autoimmune polyglandular failure - ucsf cme anderson autoimmune diseases... · library, using serum...

30
4/30/15 1 Autoimmune Polyglandular Failure Mark S. Anderson, MD, PhD Professor UCSF Diabetes Center Goals Review clinical Autoimmune Polyglandular Failure syndromes Disease spectrum Broad treatment, diagnostic recommendations Highlight newly discovered mechanism of disease for APS type I May have applications to more common autoimmune diseases

Upload: dominh

Post on 15-Feb-2019

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

1

Autoimmune Polyglandular Failure

Mark S. Anderson, MD, PhD Professor

UCSF Diabetes Center

Goals

•  Review clinical Autoimmune Polyglandular Failure syndromes

•  Disease spectrum •  Broad treatment, diagnostic recommendations

•  Highlight newly discovered mechanism of disease for APS type I

•  May have applications to more common autoimmune diseases

Page 2: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

2

Definitions

Autoimmune Polyglandular Failure broadly divided into two major categories:

•  APS type I (Whitaker’s Syndrome, APECED)

•  APS type II (Schmidt’s Syndrome)

APS I (%) APS II (%) Comparative Frequency Less Common More Common Onset Infancy/early childhood Late childhood/adulthood Heredity Autosomal Recessive Polygenic Gender Male = Females Female Predominance Genetics AIRE gene; no HLA association HLA association; DR/DQ Hypoparathyroidism 77-89 None Mucocutaneous candiditis 73-100 None Ectodermal dysplasia 77 None Addison’s Disease 60-86 70-100 Type 1 Diabetes 4-18 41-52 Autoimmune thyroid disease 8-10 70 Pernicious anemia 12-15 2-25 Gonandal failure Females 30-60 3.5-10 Males 7-17 5 Vitiligo 4-13 4-5 Alopecia 27 2 Autoimmune hepatitis 10-15 Rare Malabsorption 10-18 Rare

Page 3: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

3

APS I: Epidemiology

•  First description in 1929 •  Synonyms: Whitaker’s, Polyglandular

Autoimmune Disease Type 1, APECED •  Prevalence variable - rare outside clusters •  Phenotype typically emerges in childhood •  Males and females equally affected

APS I: Clinical Features

•  Major components: (1) Chronic mucocutaneous candidiasis (2) Chronic hypoparathyroidism (3) Autoimmune adrenal insufficiency

•  2 of the 3 required for diagnosis •  Multiple minor clinical features

Page 4: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

4

APS I: Clinical Presentation #

Cas

es (n

=41)

Betterle, JCEM 1998; 83(4):1050

Mucocutaneous Candidiasis •  Most frequent major clinical feature (93%) •  Presents: 1 month to 21 years of age •  Affects nails, dermis, oral, vaginal, and

esophageal mucosa •  Chronic infection associated with carcinoma •  Treated PRN. Fluconazole and/or Nystatin

S&S

Page 5: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

5

Why Candida?

Hypoparathyroidism

•  Second major clinical manifestation •  Occurs in 73-90% of APS 1 patients •  Presents: 3 months to 44 years of age •  Diagnosis: Ionized Ca/PTH •  Nalp5 autoantibodies as a marker

Page 6: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

6

original article

T h e n e w e ng l a nd j o u r na l o f m e dic i n e

n engl j med 358;10 www.nejm.org march 6, 20081018

Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen

Mohammad Alimohammadi, M.D., Peyman Björklund, Ph.D., Åsa Hallgren, B.Sc., Nora Pöntynen, M.Sc., Gabor Szinnai, M.D., Noriko Shikama, Ph.D.,

Marcel P. Keller, Ph.D., Olov Ekwall, M.D., Ph.D., Sarah A. Kinkel, B.Sc., Eystein S. Husebye, M.D., Ph.D., Jan Gustafsson, M.D., Ph.D., Fredrik Rorsman, M.D., Ph.D., Leena Peltonen, M.D., Ph.D.,

Corrado Betterle, M.D., Ph.D., Jaakko Perheentupa, M.D., Ph.D., Göran Åkerström, M.D., Ph.D., Gunnar Westin, Ph.D., Hamish S. Scott, Ph.D.,

Georg A. Holländer, M.D., and Olle Kämpe, M.D., Ph.D.

From University Hospital, Uppsala Uni-versity, Uppsala, Sweden (M.A., P.B., Å.H., O.E., J.G., F.R., G.Å., G.W., O.K.); Univer-sity of Helsinki and the National Public Health Institute, Biomedicum Helsinki (N.P., L.P.), and the Hospital for Children and Adolescents, Helsinki University Hos-pital ( J.P.) — both in Helsinki; Laboratory of Pediatric Immunology, University of Basel, and the University Children’s Hos-pital — both in Basel, Switzerland (G.S., N.S., M.P.K., G.A.H.); the Walter and Eliza Hall Institute of Medical Research and the University of Melbourne — both in Park-ville, Victoria, Australia (S.A.K., H.S.S.); the Institute of Medicine, University of Bergen, and Haukeland University Hos-pital — both in Bergen, Norway (E.S.H.); and the University of Padua, Padua, Italy (C.B.). Address reprint requests to Dr. Kämpe at the Department of Medical Sci-ences, Uppsala University Hospital, SE 75185, Uppsala, Sweden, or at [email protected].

N Engl J Med 2008;358:1018-28.Copyright © 2008 Massachusetts Medical Society.

A BS TR AC T

BACKGROUNDAutoimmune polyendocrine syndrome type 1 (APS-1) is a multiorgan autoimmune disorder caused by mutations in AIRE, the autoimmune regulator gene. Though re-cent studies concerning AIRE deficiency have begun to elucidate the molecular pathogenesis of organ-specific autoimmunity in patients with APS-1, the autoanti-gen responsible for hypoparathyroidism, a hallmark of APS-1 and its most common autoimmune endocrinopathy, has not yet been identified.

MethodsWe performed immunoscreening of a human parathyroid complementary DNA library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with reactivity to the NACHT leucine-rich-repeat protein 5 (NALP5). Subsequently, serum samples from 87 patients with APS-1 and 293 controls, includ-ing patients with other autoimmune disorders, were used to determine the frequency and specificity of autoantibodies against NALP5. In addition, the expression of NALP5 was investigated in various tissues.

ResultsNALP5-specific autoantibodies were detected in 49% of the patients with APS-1 and hypoparathyroidism but were absent in all patients with APS-1 but without hypo-parathyroidism, in all patients with other autoimmune endocrine disorders, and in all healthy controls. NALP5 was predominantly expressed in the cytoplasm of para-thyroid chief cells.

ConclusionsNALP5 appears to be a tissue-specific autoantigen involved in hypoparathyroidism in patients with APS-1. Autoantibodies against NALP5 appear to be highly specific and may be diagnostic for this prominent component of APS-1.

Copyright © 2008 Massachusetts Medical Society. All rights reserved. Downloaded from www.nejm.org at COLUMBIA UNIV HEALTH SCIENCES LIB on August 5, 2008 .

Addison’s Disease

•  Third major manifestation to appear •  Presents: 6 months to 41 years of age •  Adrenal cortex Ab (anti-21 Hydroxylase)

near 100% at Dx. •  Anti-adrenal Ab’s positive predicitive value •  Traditional management with corticosteroid

replacement

Page 7: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

7

APS I: Minor Clinical Features •  Hypergonadotropic

hypogonadism •  Autoimmune

hypothyroidism •  Type I diabetes •  Hypophysitis •  Pernicious anemia •  Atrophic gastritis •  Malabsorption

•  Chronic active hepatitis •  Vitiligo •  Alopecia •  Ectodermal dystrophy •  Keratoconjunctivitis •  Cellular/humoral defects •  Asplenia •  Cholelithiasis

Betterle et al. JCEM 83:1049-1055, 1998

Page 8: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

8

Hypergonadotripic Hypogonadism

•  Present in 17-50% of APS 1 patients •  Anti-Cyp450side chain or 17-OH

autoantibodies have predictive value •  Onset: pre-pubertal to age 40 •  Fertility counseling

Diabetes Mellitus Type 1

•  DM type 1 in 10% patients with APS 1 •  Most with DM: anti-GAD+ •  Many patients anti-GAD+ that do not

progress to DM •  Fasting glucose and A1C also

recommended

Page 9: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

9

Autoimmune Thyroid Disease

•  Hashimoto’s thyroiditis or atrophic thyroiditis in 10% of patients with APS 1

•  Again presence of antibodies common •  Grave’s also seen in some patients but more

rare •  Monitor TSH and antibodies

Autoimmune Gastrointestinal Disease

•  Pernicious anemia in 11-13% patients •  Mean age of onset 20 years •  Parietal cell & intrinsic factor autoantibodies

•  Malabsorption in 18-22% patients •  celiac disease, pancreatic insufficiency,

infections, intestinal lymphangectasia

Page 10: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

10

Chronic Active Hepatitis

•  Prevalence of 10 -25% of APS 1 patients •  Presentation: 5-21 years of age •  Variable clinical course •  Autoantibodies: LKM, smooth muscle,

mitochondrial, P450IA2 •  Responsive to corticosteroids and

azathioprine

Autoimmune Skin Disease

•  Vitiligo in 8-13% of patients •  Presents: 1 month to 15 years of age •  Complement-fixing melanocyte autoantibodies

•  Alopecia in 29-32% of patients •  Presents: 3-30 years of age •  Total hair loss commonly seen, psychological

impact important

Page 11: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

11

Prognosis

•  Prior to 1970 mortality was 70% by age 30 •  Mortality now 10-15% over 50 years

Betterle, JCEM 1998; 83(4):1054

100 90 80

70 60

50 40

30 20 10

0

Cum

ulat

ive

Surv

ival

(%)

0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 Years follow-up

APS 1 Clinical Recommendations

•  Affected patients have lifetime susceptibility to multiple organ-specific autoimmune diseases. Vigilant follow-up by an endocrinologist at least quarterly with replacement Rx carefully monitored.

•  Particular attention to hypocalcemia and a low threshold for working up at risk syndromes is essential

•  Immunosuppression only used in non-endocrine autoimmune diseases (i.e. autoimmune hepatitis)

•  ?Role of genetic testing and counseling now that the causative gene has been identified

On Web: http://www.geneclinics.org/servlet/access?

prg=j&db=genetests&site=gt&id=8888890&fcn=c&qry=37600&res=&key=hJaU-ilZlicSw&show_flag=c

Page 12: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

12

APS II

•  1926 Schmidt described lymphocytic infiltrate of thyroid and adrenal in two patients

•  Definition varies from author to author

APS II Definition

•  Co-existence of two or more of any of these three autoimmune diseases: •  Type 1 diabetes •  Autoimmune thyroid disease •  Addison’s disease

Page 13: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

13

APS II Clinical Syndromes

•  Major components •  Type 1 diabetes •  Autoimmune thyroid disease •  Addison’s disease

•  Minor components -Gonadal failure -Vitiligo -Pernicious anemia and/or autoimmune Gastritis -Celiac disease -Alopecia

APS II Epidemiology

•  Onset late childhood to adulthood, peak is in third decade

•  Females more commonly affected; at least 3:1 ratio

•  Genetics complex; HLA DR/DQ

Page 14: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

14

APS I (%) APS II (%) Comparative Frequency Less Common More Common Onset Infancy/early childhood Late childhood/adulthood Heredity Autosomal Recessive Polygenic Gender Male = Females Female Predominance Genetics AIRE gene; no HLA association HLA association; DR/DQ Hypoparathyroidism 77-89 None Mucocutaneous candiditis 73-100 None Ectodermal dysplasia 77 None Addison’s Disease 60-86 70-100 Type 1 Diabetes 4-18 41-52 Autoimmune thyroid disease 8-10 70 Pernicious anemia 12-15 2-25 Gonandal failure Females 30-60 3.5-10 Males 7-17 5 Vitiligo 4-13 4-5 Alopecia 27 2 Autoimmune hepatitis 10-15 Rare Malabsorption 10-18 Rare

Addison’s Disease •  50% of APS II cases present with Addison’s •  Adrenal cortex Ab (anti-21 Hydroxylase) near 100% at Dx •  Anti-adrenal Ab’s positive predicitive value •  Diagnosis based on Cortrosyn Stimulation Test, elevated

ACTH, and clinical picture (hyponatremia, hyperkalemia). •  Traditional management with corticosteroid replacement

(including mineralocorticoid rx) •  ** Should be ruled out in suspected APS patients starting

thyroid replacement

Page 15: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

15

Diabetes Mellitus Type 1

•  Screening with fasting glucose and anti-GAD, I-A2, insulin Antibodies

•  **Patients with co-existing Addison’s are excellent candidates for treatment with Glargine Insulin for prevention of hypoglycemia.

Celiac Disease •  Relatively common in APS II patients •  Disease risk very strong correlation with HLA-DQA1*0501

DQB1*0201 •  Seen in >90% of cases •  Also a risk allele for other APS II syndromes

•  Antibody screening with anti-transglutaminase and anti-endomysial antibodies as a screen. If positive small bowel biopsy if diagnosis still uncertain.

•  Antibody tests are excellent screen with anti-endomysial sensitivity and specificity 90 and 98%

Page 16: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

16

Gonadal Autoimmunity •  Occurs before age 40 in 10-20% of female

patients •  Anti-Cyp450side chain or 17-OH

autoantibodies have predictive value for disease

•  Fertility counseling

Autoantibody Screening Disease Autoantibody Sens/Spec Type 1 DM GAD, I-A2,Insulin Addison’s 21-OH Thyroid TPO, Tg, TSI All generally>90% Sens

BUT **Spec <90% Ovarian Cyp450side chain Pernicious Anemia Parietal Cell Celiac Endomysial, Gliadin **>90%/98%

Page 17: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

17

APS II Clinical Recommendations

•  Affected patients have lifetime susceptibility to multiple organ-specific autoimmune diseases. Vigilant follow-up by an endocrinologist at least bi-annually with replacement Rx carefully monitored.

•  Celiac disease should be screened for with autoantibody testing

•  Females are at risk for premature ovarian failure and this should be carefully assessed

•  Screening for Vit B12 deficiency at least annually •  ** in newly diagnosed patients care must be taken with

starting thyroid replacement to rule out Addison’s disease.

Given the severity of autoimmunity in these

syndromes, can they provide a clue as to how autoimmune

disease occurs?

Page 18: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

18

APS I: Genetics

•  Autosomal recessive •  Populations specific incidence

•  1 in 25,000 Finland •  1 in 9,000 Iranian Jewish descent •  Sardinia

•  Founder effect and genetic isolation •  No HLA association •  Variable phenotype among siblings

APECED: Genetics

p11-

13

q11

q21.

1

q21.

2

q21.

3

q22.

11

q22.

12

q22.

13

q22.

2

q22.

3

Chromosome 21

D21

S156

D

21S4

16

D21

S224

D

21S2

35

D21

S212

D

21S1

225

D21

S49

PFK

L D

21S1

71

Aaltonen, Nature Genetics 1994; 8(1):83 APECED

Page 19: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

19

APECED Gene

•  1997: Two groups simultaneously reported isolation of the APECED gene by positional cloning

•  13 kb long, 14 exons, 545 amino acids •  AIRE (autoimmune regulator) protein

Nature Genetics 1997; 17(4):393-398, 399-403

AIRE Protein

L=LXXLL HSR =Dimerization domain NLS =Nuclear Localization Signal PHD=PHD-like domain PRR=Pro rich region SAND=putative DNA binding domain

L

7-11

63-6

7

299

340

350

407

434

475

516-

520

545

aa

L L PHD PHD PRR

280

189

105

SAND HSR

NLS

=missense mutation =nonsense STOP mutation =insertion frameshift or deletion frameshift

Page 20: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

20

Where is the AIRE gene expressed?

Real Time-PCR Analysis of Different Tissue Types

0102030405060708090

100

Thym

usLy

mph

Nod

eSp

leen

Panc

reas

Stom

ach

Saliv

ary

Kid

ney

Live

rLu

ngH

eart

Adr

enal

Ova

ryEy

eTh

yroi

d0102030405060708090

100

Thym

usLy

mph

Nod

eSp

leen

Panc

reas

Stom

ach

Saliv

ary

Kid

ney

Live

rLu

ngH

eart

Adr

enal

Ova

ryEy

eTh

yroi

d

Arbit

rary U

nits

Page 21: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

21

Thymus Architecture

Aire is expressed in thymic medullary epithelial cells

c

m

Page 22: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

22

Thymus Architecture

Do AIRE knockout mice exhibit autoimmunity?

Page 23: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

23

Salivary Ovary Retina

V

V

KO

WT

Multi-organ Immune Infiltrates

KO

WT

Ovary Stomach Retina

mu

p

m

m

p

mu

o

o

cpen

in

cpenin

f

f

Ovary Stomach Retina

mu

p

m

m

p

mu

o

o

cpen

in

cpenin

f

f

Multi-organ Autoantibodies

Page 24: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

24

Summary of KO Phenotype

• AIRE knockout mice develop autoimmunity in an organ-specific pattern that worsens with age

• Careful immunological analysis of the mice and wild-type controls reveal:

• Many parameters are unchanged

• Increase in medullary epithelial cells in the thymus

• Increase in T cells with an “activated-memory” phenotype in peripheral lymph nodes

Is the defect in the bone marrow derived or stromal compartment?

Page 25: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

25

BM Chimera Experiment

1000 Rad

KO

BM Donor

WT

WT

KO

WT

KO

Recipient Infiltrates and AutoAb’s ?

No

No

Yes

Yes

Is the thymus responsible?

Page 26: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

26

Thymic Transplant Experiment Thymic Donor

Recipient Infiltrates and AutoAb’s ?

No

Yes

WT Athymic Nude

dGuo Rx’d

Athymic Nude

dGuo Rx’d

Newborn

KO Newborn

What about gene expression in the thymic medullary

epithelium?

Page 27: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

27

Thymic Epithelial Cells

CD

R1

B7-1

1.81

0.98

Thymic Epith.

KO

WT

Gene Chip Analysis of Medullary Thymic Epithelium KO vs WT

Page 28: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

28

SOME PERIPHERAL GENE TRANSCRIPS ECTOPICALLY EXPRESSED IN THE THYMUS

Insulin GAD 67 IA-2

Retinal S-Ag Crystallin

MOG Proteolipid Protein

Serum amyloid protein C-reactive protein a-Fetoprotein

pancreas

eye

CNS

liver

Gene Chip Analysis of Medullary Thymic Epithelium KO vs WT

Page 29: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

29

several specific tissues housekeeping

Probe name Gene name Tissue(s)

WT signal

KO signal

KO/ WT

t-test p-val

FPR Quad

FPR SAM

96030_at casein alpha mammary 75.62 1 0.013 0.0417 0.043 0.014

97180_f_athemoglobin y, beta-like embryonic chain fetal erythrocytes 87.36 1.29 0.015 0.0803 0.279 0.014

100106_at intestinal trefoil factor intestinal goblet cells 74.59 1.99 0.027 0.0504 < 0.02 0.014101820_at neurotoxin homologue granulocytes, monocytes 29.50 1 0.034 0.1105 < 0.02 0.014

94738_s_at

defensin-related cryptdin,related sequence 2 Paneth cells 100.47 3.85 0.038 0.2561 0.164 -

101682_f_at major urinary protein IVlachrymal gland, parotid gland 26.49 1.2 0.045 0.0392 0.063 0.014

94153_g_at salivary protein 1 salivary gland 22.62 1.06 0.047 0.0712 0.131 0.014102998_at cytochrome P450 1a2 liver, lung, duodenum 20.99 1.01 0.048 0.0868 0.043 0.014101115_at lactotransferrin mammary gland, uterus 19.78 1 0.051 0.0320 0.043 0.01492353_at serine protease (BSSP) hair follicles, brain 18.77 1 0.053 0.1070 1 -100463_at gamma-casein precursor mammary gland 21.93 1.17 0.053 0.0596 0.071 0.01492546_r_at prostaglandin D brain, epididymis 22.82 1.26 0.055 0.0001 0.063 0.01496153_at neutrophilic granule granulocytes 28.46 1.72 0.060 0.0246 0.063 0.014160899_at Purkinje cell protein 4 brain, eye (lens) 32.67 2.09 0.064 0.0327 < 0.02 0.014161815_f_at major urinary protein I liver 31.23 2.04 0.065 0.0704 0.043 0.014

98858_atglucose dependent insulinotropic polypeptide K cells of small intestine 27.16 1.78 0.066 0.0517 < 0.02 0.014

101910_f_at major urinary protein 3 liver 21.02 1.47 0.070 0.0328 0.164 0.01494775_at oxytocin brain 26.59 1.92 0.072 0.0334 1 -101636_at salivary protein 2 salivary gland 16.80 1.23 0.073 0.0382 1 -

98623_g_at insulin-like growth factor IIembryo, choroid plexus and leptomeninges in adult 94.85 6.96 0.073 0.1179 < 0.02 0.014

99958_at mast cell protease-2 mast cells 13.70 1.01 0.074 0.0248 0.043 0.01494707_s_at amelogenin ameloblast cells 34.69 2.57 0.074 0.0328 < 0.02 0.014103235_at preproneuropeptide y brain 19.54 1.47 0.075 0.0143 0.043 0.014

103887_atS100 calcium binding protein A9

immature BM myeloid cells, monocytes, neutrophils 68.93 5.26 0.076 0.1529 0.279 0.014

162341_r_at aldose reductase many 19.37 1.48 0.076 0.0121 0.279 -97889_at fatty acid binding protein intestine 37.46 3.04 0.081 0.0254 0.043 0.014

94045_atα-1-microglobulin/bikunin precursor liver 12.74 1.04 0.082 0.0781 0.279 0.014

100150_f_at preproinsulin II pancreatic islet beta cells 19.70 1.62 0.082 0.1692 < 0.02 0.014

100002_atinter-alpha-inhibitor H3 chain liver, brain 12.07 1 0.083 0.0266 0.043 0.014

98830_at spermine binding protein prostate 13.56 1.13 0.083 0.1047 0.131 -

One specific tissue hematopoietic cells

Top 30 genes down-regulated in KO samples on Affymetrix chip

Model: AIRE Projects a Self-Shadow in the Thymus

TCR

MHC + Peptide

Autoreactive

T cell

Thymic Medullary Cell

AIRE ? Self Peptides from “Organ Specific”

Antigens

Deletion of Autoreactive T

cell

Page 30: Autoimmune Polyglandular Failure - UCSF CME Anderson Autoimmune Diseases... · library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with

4/30/15

30

Summary •  The single gene defect behind APECED or

APS 1 highlights the importance of self-antigen presentation in the thymus

•  This process may play an important role in more common autoimmune disorders •  Type 1 Diabetes- Insulin gene risk human

subjects

Summary (Cont) •  New autoantibodies in APS1:

-anti-NALP5- hypoparathyroidism -anti-IL-22, IL-17 autantobodies- candida